Scott Tarriff | CEO |
Pete Meyers | CFO |
Ilanit Allen | In-Site Communications, Inc., IR |
David Amsellem | Piper Jaffray |
Randall Stanicky | RBC Capital Markets |
Gregg Gilbert | Deutsche Bank |
Tim Lugo | William Blair |
Good day, and welcome to today’s program. My name is Erica, and I’ll be your conference operator. At this time, I’d like to welcome everyone to Eagle Pharmaceuticals’ First Quarter 2018 Earnings Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer period.